-
Most Recent
Search Results
240 results for abb
AbbVie Earnings: 5 Things for ABBV Stock Investors to Note
AbbVie (ABBV) earnings for the biopharmaceutical company’s third quarter of 2019 have ABBV stock up Friday on an EPS and revenue beat.
AI’s $700 Billion Question
Alphabet says AI demand is outrunning supply … AWS logs its fastest growth in four years … Meta beats but pulls back 10% … and…
AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions
With AbbVie’s buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.
ABB: A ‘Steady Eddy’ Stock for Turbulent Times
ABB is a diversified machinery company that combines a global industrial presence with high-tech innovation for low-risk growth. It’s a safe harbor in a choppy…
As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock
AbbVie has tools with which to mask a slowdown in Humira sales, and an extensive drug pipeline, but the risks in the stock are rising
AbbVie Is Cheap and Pays an Attractive Yield
AbbVie stock is both cheap and has an attractive dividend yield. AbbVie stock sells below 10x earnings, with a 4.9% dividend yield and a 28%…
Humira Sales Help AbbVie Inc (ABBV) to a Q1 Earnings Beat
AbbVie Inc, a pharmaceuticals company, has released its earnings report for the first quarter of 2015 and it beat analysts’ estimates
AbbVie Stock Could Become a New Happy Pill for Investors
Worries about losing the Humira patent have weighed on AbbVie, but now ABBV stock brings opportunity for both growth and income investors.
Best Stocks for 2022: Up 20% This Year, AbbVie Is Doing Great
AbbVie is great for dividend investors, and it’s great for people looking for growth in 2022. The company’s guidance for 2022 is exciting.
AbbVie Earnings: ABBV Stock Jumps More Than 6% on Q4 Beats
AbbVie (ABBV) earnings for the biopharmaceutical company’s fourth quarter of 2019 have ABBV stock heading higher on Friday.
AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today
AbbVie stock is the top trending ticker on Yahoo Finance Thursday earnings news has ABBV investors pumped up this morning.
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500.
AbbVie Inc Stock Up on Strong Earnings, Guidance Update
AbbVie (ABBV) stock was up on Thursday following the release of a positive earnings report for the first quarter of the year.
AbbVie Stock – Good for Income, Bad for Growth
AbbieVie stock is fully valued, but with a forward dividend yield of 3.5%, income investors should consider buying ABBV stock.
Great Yield and Packed Pipeline Signal a Buy for AbbVie
Investors can still own AbbVie stock at a good price, even in the wake of a potentially lifesaving collaboration.
Strong Buy for AbbVie (ABBV) This Week
AbbVie (ABBV) remains a Strong Buy this week based on the most current relative pricing of its shares and analysis.
Strong Buy for AbbVie (ABBV) This Week
The Strong Buy for AbbVie (ABBV) this week is based on the latest stock market rankings, and relative pricing of its shares.
Steal Some Yield and Bet on Clinical Clout With ABBV Stock
ABBV stock investors can collect dividend payments but also expect share-price upside as AbbVie continues to clear regulatory hurdles.
AbbVie (ABBV) a Strong Buy at $114.56
AbbVie (ABBV) a Strong Buy at $114.56 based on the most current analysis, and comparative pricing of its shares.
AbbVie (ABBV) a Strong Buy at $114.56
AbbVie (ABBV) a Strong Buy at $114.56 based on the most current analysis, and comparative pricing of its shares.
Trade of the Day: AbbVie (ABBV)
In 2017, Humira raked in $18.9 billion in sales for AbbVie (ABBV) and, according to the company’s latest earnings announcement, that sales rate grew by…
AbbVie Inc. Is a Clear Value Play in Biotech Stocks
AbbVie stock is not bouncing back after investors bailed on it following potentially negative clinical results. For value investors, ABBV trades at a discount to…
AbbVie Inc Stock Soars on Strong Q4 Earnings Beat
AbbVie (ABBV) stock was flying high today following the release of a positive earnings report for the fourth quarter of 2017.
3 – 10 of 240 results
